Single Cell Analysis Market 2024-2028: Size and High cost of single cell analysis products; growth driven by the Product, Some of key Companies Positioned Strategically

The single cell analysis market size by Product (Consumables and Instrument) and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 3591.6 million. The market is expected to grow at a CAGR of   16.6% between 2024 and 2028.

• Medium- and small-scale testing laboratories and research institutions face budget constraints when it comes to purchasing advanced testing instruments, such as mass spectrometers. In developing regions, this is particularly prevalent as there are numerous small- and medium-scale laboratories and institutes with limited financial resources. To circumvent this challenge, these institutions often collaborate with other organizations for research activities. However, outsourcing sample analysis or relying on external proteomics specialists can introduce potential errors and misinterpretations. The affordability and accessibility of single cell analysis solutions, therefore, represent significant opportunities for market growth. These solutions can provide cost-effective, accurate, and efficient analysis capabilities to these institutions, enabling them to conduct in-house research and reduce reliance on external collaborations.
• The Single Cell Analysis market is experiencing significant growth due to the increasing demand for advanced diagnostic and therapeutic solutions. This technology enables the analysis of individual cells, providing valuable insights into genetic and proteomic variations that are crucial for personalized medicine. Companies are investing heavily in R&D to improve the sensitivity and throughput of single cell analysis platforms, making them increasingly accessible to researchers and clinicians. This trend is expected to continue, with the market projected to reach substantial value by 2025.

Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:

• 10X Genomics Inc.
• Agilent Technologies Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• Bio Techne Corp.
• CellChorus Inc.
• Danaher Corp.
• DiaSorin SpA
• Fluidigm Corp.
• Illumina Inc.
• Merck KGaA
• NanoString Technologies Inc.
• QIAGEN NV
• RareCyte Inc
• Sartorius AG
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.
• Yokogawa Electric Corp.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/